Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Nanjing Kangerjia Medical Technology Co., Ltd.
0 Patents (Medical) associated with Nanjing Kangerjia Medical Technology Co., Ltd.
100 Deals associated with Nanjing Kangerjia Medical Technology Co., Ltd.
100 Translational Medicine associated with Nanjing Kangerjia Medical Technology Co., Ltd.